Explanation
BACKGROUND: This ordinance authorizes the option to purchase Nexplanon (Etonogestrel Implant) for the Columbus Public Health Department. The term of the proposed option contract will be through December 31, 2018 with the option to extend one additional one (1) year period, subject to mutual agreement of both parties in accordance with Sole Source Solicitation No. SA006055. There has been a great demand for Nexplanon (Etonogestrel Implant) to provide continuous contraceptive services through the Women’s Health Clinic. The clinic is experiencing problems with keeping a supply of this product. Theracom LLC is the only distributor of this product as provided by the Health Department.
The Purchasing Office negotiated the universal term contract in accordance with the provisions of a sole source procurement. This product is not available to the Health Department from any other source.
This company is not debarred according to the Excluded Parties listing of the Federal Government and is not listed in the Auditor of State database for Findings for Recovery.
The Purchasing Office is recommending award of one contract to TheraCom LLC.
CC#522005869, Expiration: 7/9/2017.
Total Estimated Annual Expenditure: $60,000.00
This ordinance is being submitted as an emergency because without emergency action the contraceptive services will be delayed and the efforts of the Health Department to maintain a supply of the Nexplanon (Etonogestrel Implant) will be affected and the efficient delivery of valuable public services will be slowed.
FISCAL IMPACT: Funding to establish this option contract is budgeted in the General Fund. The Health Department will be required to obtain approval to expend from their own appropriations.
Title
To authorize the Finance and Management Director to enter into one contract for the option to purchase Nexplanon (Etonogestrel Implant) from TheraCom LLC. To authorize the expenditure of one dollar ($1.00) to establish a contract ...
Click here for full text